These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35143100)

  • 41. Humoral response to SARS-CoV-2 adenovirus vector vaccination (ChAdOx1 nCoV-19 [AZD1222]) in heart transplant recipients aged 18 to 70 years of age.
    Tanner R; Starr N; Chan G; Dempsey E; Heffernan E; Newman E; O'Neill J; Hannan MM; Lynch B; Joyce E
    J Heart Lung Transplant; 2022 Apr; 41(4):492-500. PubMed ID: 35090809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kidney transplant recipients' attitudes toward COVID-19 vaccination and barriers and enablers to vaccine acceptance.
    Tharmaraj D; Dendle C; Polkinghorne KR; Mulley WR
    Transpl Infect Dis; 2022 Feb; 24(1):e13749. PubMed ID: 34694682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Humoral Response After SARS-CoV-2 Vaccination in Kidney Transplant Recipients: Role of Immunosuppression Therapy.
    López V; Polo C; Schuldt R; Vázquez T; Gutiérrez-Vílchez E; Moliz C; Hernández D
    Transplant Proc; 2022 Nov; 54(9):2454-2456. PubMed ID: 36273957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cellular and humoral immune response after mRNA-1273 SARS-CoV-2 vaccine in liver and heart transplant recipients.
    Herrera S; Colmenero J; Pascal M; Escobedo M; Castel MA; Sole-González E; Palou E; Egri N; Ruiz P; Mosquera M; Moreno A; Juan M; Vilella A; Soriano A; Farrero M; Bodro M
    Am J Transplant; 2021 Dec; 21(12):3971-3979. PubMed ID: 34291552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The type of SARS-CoV-2 vaccine influences serological response in kidney transplant recipients.
    Correia AL; Leal R; Pimenta AC; Fernandes M; Guedes Marques M; Rodrigues L; Santos L; Romãozinho C; Sá H; Pratas J; Araújo L; Figueiredo A; Alves R
    Clin Transplant; 2022 Apr; 36(4):e14585. PubMed ID: 34997797
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
    Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: A population-based cohort study from Canada.
    Naylor KL; Kim SJ; Smith G; McArthur E; Kwong JC; Dixon SN; Treleaven D; Knoll GA
    Am J Transplant; 2022 Sep; 22(9):2228-2236. PubMed ID: 35578576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of age and rural residency on perceptions about SARS-CoV-2 pandemic and vaccination in kidney transplant recipients.
    Singh G; DeWalle J; Tanriover B; Singh N; Chang AR; Anand PM
    Transpl Infect Dis; 2022 Dec; 24(6):e13943. PubMed ID: 36169231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. COVID-19 Vaccines in Pancreatic Transplant Recipients: A Single-Center Observative Study.
    Matejak-Górska M; Zielonka M; Górska H; Durlik M
    Transplant Proc; 2022 May; 54(4):925-929. PubMed ID: 35437149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021: a prospective, multicentre cohort study.
    Hall VG; Solera JT; Al-Alahmadi G; Marinelli T; Cardinal H; Poirier C; Huard G; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Humar A; Kumar D
    CMAJ; 2022 Aug; 194(33):E1155-E1163. PubMed ID: 36302101
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mycophenolate mofetil decreases humoral responses to three doses of SARS-CoV-2 vaccine in liver transplant recipients.
    Meunier L; Sanavio M; Dumortier J; Meszaros M; Faure S; Ursic Bedoya J; Echenne M; Boillot O; Debourdeau A; Pageaux GP
    Liver Int; 2022 Aug; 42(8):1872-1878. PubMed ID: 35338550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunogenicity of SARS-CoV-2 mRNA vaccine in solid organ transplant recipients.
    Holden IK; Bistrup C; Nilsson AC; Hansen JF; Abazi R; Davidsen JR; Poulsen MK; Lindvig SO; Justesen US; Johansen IS
    J Intern Med; 2021 Dec; 290(6):1264-1267. PubMed ID: 34237179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reported cases of multisystem inflammatory syndrome in children aged 12-20 years in the USA who received a COVID-19 vaccine, December, 2020, through August, 2021: a surveillance investigation.
    Yousaf AR; Cortese MM; Taylor AW; Broder KR; Oster ME; Wong JM; Guh AY; McCormick DW; Kamidani S; Schlaudecker EP; Edwards KM; Creech CB; Staat MA; Belay ED; Marquez P; Su JR; Salzman MB; Thompson D; Campbell AP;
    Lancet Child Adolesc Health; 2022 May; 6(5):303-312. PubMed ID: 35216660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.
    Stock PG; Henrich TJ; Segev DL; Werbel WA
    J Clin Invest; 2021 Jul; 131(14):. PubMed ID: 34143755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of the safety and immunogenicity of the BNT-162b2 vaccine and the ChAdOx1 vaccine for solid organ transplant recipients: a prospective study.
    Ajlan AA; Ali T; Aleid H; Almeshari K; DeVol E; Alkaff MA; Fajji L; Alali A; Halabi D; Althuwaidi S; Alghamdi S; Ullah A; Alrajhi A; Bzeizi K; Almaghrabi R; Marquez KAH; Elmikkaoui B; Albogumi E; Aldakhil H; Al-Awwami M; Broering DC
    BMC Infect Dis; 2022 Oct; 22(1):786. PubMed ID: 36229772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of COVID 19 vaccination on kidney recipients.
    Marzieh L; Elahe P; Habib R; Maryam P; Arefeh J; Elnaz E; Sanaz D
    Transpl Immunol; 2022 Oct; 74():101658. PubMed ID: 35777613
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients.
    Crane C; Phebus E; Ingulli E
    Pediatr Nephrol; 2022 Feb; 37(2):449-453. PubMed ID: 34522992
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapamycin and inulin for booster vaccine response stimulation (RIVASTIM)-rapamycin: study protocol for a randomised, controlled trial of immunosuppression modification with rapamycin to improve SARS-CoV-2 vaccine response in kidney transplant recipients.
    Tunbridge M; Perkins GB; Singer J; Salehi T; Ying T; Grubor-Bauk B; Barry S; Sim B; Hissaria P; Chadban SJ; Coates PT
    Trials; 2022 Sep; 23(1):780. PubMed ID: 36109788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients.
    Danthu C; Hantz S; Dahlem A; Duval M; Ba B; Guibbert M; El Ouafi Z; Ponsard S; Berrahal I; Achard JM; Bocquentin F; Allot V; Rerolle JP; Alain S; Touré F
    J Am Soc Nephrol; 2021 Sep; 32(9):2153-2158. PubMed ID: 34135083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Medical decisions in organ donors and heart transplant candidates with history of COVID-19 infection: An international practice survey.
    Sadeh B; Ugolini S; Pinzon OW; Potapov EV; Selzman CH; Bader F; Zuckermann AO; Gomez-Mesa JE; Shah KS; Alharethi R; Morejon-Barragan P; Hanff T; Goldraich LA; Farrero M; MacDonald PS; Drakos S; Mehra MR; Stehlik J
    Clin Transplant; 2022 Jul; 36(7):e14733. PubMed ID: 35652422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.